M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.52 EUR -3.34% Market Closed
Market Cap: 104.5m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Maat Pharma SA
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maat Pharma SA
Operating Expenses Peer Comparison

Comparables:
VLA
G
GNFT
IVA
ALERS
OSE

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
M
Maat Pharma SA
PAR:MAAT
Operating Expenses
-€21.6m
CAGR 3-Years
-60%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Operating Expenses
-€222m
CAGR 3-Years
-11%
CAGR 5-Years
-29%
CAGR 10-Years
-17%
G
Genfit SA
PAR:GNFT
Operating Expenses
-€58m
CAGR 3-Years
2%
CAGR 5-Years
8%
CAGR 10-Years
-12%
Inventiva SA
PAR:IVA
Operating Expenses
-€115.6m
CAGR 3-Years
-48%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Operating Expenses
-€53.8m
CAGR 3-Years
-19%
CAGR 5-Years
-21%
CAGR 10-Years
-10%
OSE Immunotherapeutics SA
PAR:OSE
Operating Expenses
-€29.5m
CAGR 3-Years
7%
CAGR 5-Years
-7%
CAGR 10-Years
N/A

See Also

What is Maat Pharma SA's Operating Expenses?
Operating Expenses
-21.6m EUR

Based on the financial report for Dec 31, 2023, Maat Pharma SA's Operating Expenses amounts to -21.6m EUR.

What is Maat Pharma SA's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-37%

Over the last year, the Operating Expenses growth was -47%. The average annual Operating Expenses growth rates for Maat Pharma SA have been -60% over the past three years , -37% over the past five years .

Back to Top